RNA Technologies Empowering Small Molecule Therapeutics

RNA Technologies Empowering Small Molecule Therapeutics

RELEASE DATE
10-Aug-2018
REGION
Global
Research Code: D951-00-20-00-00
SKU: CI00554-GL-TA_22177

$950.00

Special Price $712.50 save 25 %

In stock
SKU
CI00554-GL-TA_22177

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This Drug Discovery TOE highlights the innovations in small molecule therapies targeting RNA. The key technology trends highlighted include in-silico assays, RNA drugs, nanoparticle delivery platforms, and a clinical trial summary of small molecule therapies targeting RNA.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: RNA-modifying enzymes, targeted small molecules, RNA therapy, short hairpin RNA, mRNA, RNAi, nanoparticle therapy, rare disease therapy, splicing

Table of Contents

Innovations in Drug Discovery and Development

  • Best Suited Epigenetic Targets via RNA-modifying Enzymes
  • Synthetic Short Hairpin RNA Platform Technology
  • Modular mRNA Therapeutic Platform Technology
  • Multivalent RNA Molecule as RNAi Trigger
  • Small Molecules Drugs that Can Exploit Dynamic Nature of RNA
  • Nanoparticle-based Targeted Cancer Therapeutics
  • RNA as a Target for Treating Rare Genetic Disorders
  • mRNA as a Target for Small Molecules
  • Targeting RNA Splicing Mechanism for a Genetic disorder

Drug DiscoveryTechnology Focus and Trends

  • Clinical Trial Analysis
  • Industry Interactions
Related Research
This Drug Discovery TOE highlights the innovations in small molecule therapies targeting RNA. The key technology trends highlighted include in-silico assays, RNA drugs, nanoparticle delivery platforms, and a clinical trial summary of small molecule therapies targeting RNA. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: RNA-modifying enzymes, targeted small molecules, RNA therapy, short hairpin RNA, mRNA, RNAi, nanoparticle therapy, rare disease therapy, splicing
More Information
No Index No
Podcast No
Industries Cross Industries
WIP Number D951-00-20-00-00
Is Prebook No
Ti Codes D904,D913,D91A,D91B,D933,D935,D950